US Health Secretary Kennedy says HHS to launch campaign to encourage wearable devices
June 24 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. said on Tuesday that the Department of Health and Human Services plans to launch an advertising campaign to encourage Americans to adopt wearable devices, such as those that measure heart rate or blood glucose levels.
Shares of continuous glucose-monitoring device makers Abbott (ABT.N), opens new tab and Dexcom (DXCM.O), opens new tab were up 3.6% and 10%, respectively, in afternoon trading.
"We think that wearables are a key to the MAHA agenda, Making America Healthy Again ... my vision is that every American is wearing a wearable within four years," Kennedy said, speaking before the U.S. House of Representatives Committee on Energy and Commerce's Subcommittee on Health during a hearing on his department's 2026 budget request.
"It's a way of people can take control over their own health ... they can see what food is doing to their glucose levels, their heart rates and a number of other metrics as they eat it," he added.
Kennedy also described the campaign as "one of the biggest" in the agency's history.
Kennedy, who has long promoted healthy eating over medicine as a way to combat obesity and has been a prominent critic of vaccine safety, has also been critical about Novo Nordisk's (NOVOb.CO), opens new tab diabetes drug Ozempic, which is often prescribed for weight loss.
However, he has expressed support for prescription of such weight-loss drugs for adults with morbid obesity and diabetes, provided it is accompanied by exercise.
"You know the Ozempic is costing $1300 a month, if you can achieve the same thing with an $80 wearable, it's a lot better for the American people," Kennedy said, adding, "We're exploring ways of making sure that those costs can be paid for."
J.P.Morgan analyst Robbie Marcus commented, "We think it's premature to interpret this as a direct comment on whether Medicare and other commercial payors will move towards covering non-intensive Type II diabetes patients or other areas of proactive monitoring."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
32 minutes ago
- Daily Mail
I'm always tired, so I tried a celebrity-loved injectable that promises to boost your energy and make you more productive - but does it work?
I know there are few things more boring than hearing about how tired and busy other people are, but let's just say that, as a full-time working mother with two kids under five, I am more tired and busy than I've ever been before. So when I had the opportunity to test out NAD+, a molecule that's had the wellness world buzzing with its promise to increase energy, super-charge focus, enhance your mood and improve your sleep, I was definitely interested. After having my second child I've been left with a brain fog that rarely lifts outside of work, and I've always been a terrible sleeper. Who wouldn't want to be a more productive, get-up-and-go version of themselves?
The Independent
2 hours ago
- The Independent
Tens of thousands of women forced to travel out of state for abortion care after Roe v Wade was overturned in 2022
Tens of thousands abortion patients have been forced to leave their home states to seek abortion care three years after the end of constitutionally protected abortion access in America. One out of every seven abortion patients, or roughly 155,000 people, left their home state for abortion care last year, according to the Guttmacher Institute, a reproductive health research group. That total is slightly fewer than the 170,000 people who traveled for abortion care in 2023, but it remains a remarkable spike in abortion-related travel compared to the years before the Supreme Court's June 2022 decision in Dobbs v Jackson Women's Health Organization, which overturned Roe v Wade and allowed states to criminalize abortion care and implement outright bans. Out-of-state travel for abortion care has virtually doubled since that ruling. Since the Dobbs decision, 13 states have outlawed abortions in virtually all circumstances, creating a patchwork of abortion access across the country, and balkanized legal constraints for patients and providers, who are shielded in some states and criminalized in others. The total number of abortions each year has also steadily increased in the wake of that decision. In 2024, 1.14 million abortions occurred in the United States, according to the Society for Family Planning. Roughly one in four abortions were performed through telehealth last year, with an average of 12,330 abortions per month performed through medication abortion, which typically requires a two-drug protocol that a patient can take at home. That's up from one in five in 2023 and one in every 20 in 2022. Medication abortion has accounted for the vast majority of abortions in recent years. Roughly 63 percent of all abortions are now medication abortions, according to Guttmacher. Mifepristone, one of two prescription drugs used in medication abortions, is approved for use by the FDA up to 10 weeks of pregnancy. From 2019 through 2020, nearly 93 percent of all abortions were performed before the 13th week, according to the Centers for Disease Control and Prevention. But the drug is at the center of legal challenges fueled by right-wing anti-abortion activist groups who have sought to strip the government's approval and implement sweeping federal bans on abortion care. President Donald Trump's administration has also pledged to revisit the drug's approval, using spurious reporting and junk science, in an apparent attempt to undermine the basis for the government's approval. Nearly half of patients who traveled for an abortion last year came from states where abortion is outlawed — including more than 28,000 Texas residents, more than any other state, Guttmacher found. 'While these findings show us where and how far patients are traveling, they are not able to capture the numerous financial, logistical, social and emotional obstacles people face,' according to Guttmacher Institute data scientist and study lead Isaac Maddow-Zimet. In the months after the Dobbs decision, sweeping anti-abortion restrictions across the deep South and neighboring states have effectively forced abortion patients to travel hundreds of miles to reach the nearest state where abortion access was legal. Florida, surrounded by anti-abortion states, was initially a key point of abortion access in the South within the first two years after the Dobbs decision. In 2023, more than 9,000 people traveled from other states to get an abortion there, according to Guttmacher. Roughly one in every two abortions nationwide and one in three abortions in the South were performed in Florida at that time. Last year, Florida banned abortion beyond six weeks of pregnancy, before many women know they are even pregnant, and the number of patients traveling to the state for abortion care was virtually cut in half. Another 8,000 people left the state to get an abortion elsewhere, often crossing as many as three states to get there, Guttmacher found. 'It was not just Floridians who were impacted, but also the thousands of out-of-state patients who would have traveled there for care,' according to Candace Gibson, Guttmacher Institute Director of State Policy. 'The most extreme abortion bans are concentrated in the South, which makes it disproportionately difficult for people living in that region to exercise their fundamental right to bodily autonomy,' she added.
The Guardian
2 hours ago
- The Guardian
CDC vaccine report cites study that does not exist, says scientist listed as author
A review on the use of the preservative thimerosal in vaccines slated to be presented on Thursday to the US Centers for Disease Control and Prevention's (CDC) outside vaccine committee cites a study that does not exist, the scientist listed as the study's author said. The report, called Thimerosal as a Vaccine Preservative published on the CDC website on Tuesday, is to be presented by Lyn Redwood, a former leader of the anti-vaccine group Children's Health Defense. It makes reference to a study called Low-level neonatal thimerosal exposure: Long-term consequences in the brain, published in the journal Neurotoxicology in 2008, and co-authored by UC Davis professor emeritus Robert Berman. But according to Berman, 'it's not making reference to a study I published or carried out.' Berman said he co-authored a similarly named study in a different journal – Toxicological Sciences – that came to different conclusions than those suggested by Redwood. 'We did not examine the effects of thimerosal in microglia … I do not endorse this misrepresentation of the research,' he said. Reuters is the first to report on the inaccurate citation from Redwood's planned presentation. The meeting has become increasingly controversial after the US health secretary Robert F Kennedy Jr, just weeks ago abruptly fired all previous 17 members of the expert panel and named eight new members, half of whom have advocated against vaccines. Kennedy, a long-time anti-vaccine activist, founded the Children's Health Defense. Both Republican senator Bill Cassidy of Louisiana and Democratic senator Patty Murray of Washington state said the meeting on 25 and 26 June should be postponed. The summary of the presentation suggested that there are enough thimerosal-free flu vaccines and that all pregnant women, infants and children should receive only those shots. It was not clear if the new advisory panel would be asked to vote on such a move. Redwood's presentation was in contrast to a separate report posted by CDC staff on the CDC website on Tuesday that says evidence does not support a link between thimerosal-containing vaccines and autism or other neurodevelopmental disorders. Kennedy has long pushed a link between vaccines and autism contrary to scientific evidence. Redwood could not be immediately reached for comment. An HHS spokesperson said the study being referenced was the Toxicological Sciences study Berman said was being misrepresented. The CDC's briefing material reviewed some studies on neurodevelopmental outcomes and vaccines that contain thimerosal, which has long been used in the US in multi-dose vials of medicines and vaccines to prevent germs from growing in them. According to the CDC report, 96% of all influenza vaccines in the US were thimerosal free during the 2024-25 flu season. It also added that the number of pregnant women receiving a thimerosal-containing flu vaccine has decreased over time, with only 0.3% of doses given in 2024 containing thimerosal. Kennedy wrote a book in 2014 claiming that thimerosal, a mercury-based preservative, causes brain damage. On Monday, Cassidy, who heads the US Senate committee on health, education, labor and pensions, called for the meeting to be delayed, saying it should not take place with a relatively small panel and without a CDC director in place. Murray, a senior member and former chair of the Help Committee, has also called for the fired panel members to be reinstated or the meeting be delayed until new members are appropriately vetted.
